Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion
In Brief: Mansfield To Head NCI Radiation Research; Cowan Is Acting Chief, Medicine Branch
Univ. of Chicago Hospital Apologizes For Overdose Death
DCT Advisors Approve Recompetition Of Drug Discovery Groups
Gastrointestinal SPORE To Be Recompeted
Letter: ORI And Plotkin Should Release Report
Small Business Technology Transfer Program Solicitation
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









